Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia

Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia

<p><strong>Introduction:</strong> The potential impact of socio-economic condition on virological suppression during antiretroviral treatment (ART) in sub-Saharan Africa is largely unknown. In this case-control study, we compared socio-economic factors among Ethiopian ART recipient...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Plymoth, M, Sanders, EJ, Van Der Elst, EM, Medstrand, P, Tesfaye, F, Winqvist, N, Balcha, T, Björkman, P
Format:	Journal article
Język:	English
Wydane:	Public Library of Science 2020

Podobne zapisy

Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia.
od: Martin Plymoth, i wsp.
Wydane: (2020-01-01)

Development of an algorithm for determination of the likelihood of virological failure in HIV-positive adults receiving antiretroviral therapy in decentralized care
od: Anton Reepalu, i wsp.
Wydane: (2017-01-01)

Low-level viremia in people with HIV in Ethiopia is associated with subsequent lack of viral suppression and attrition from care
od: Ilili Jemal Abdulahi, i wsp.
Wydane: (2025-12-01)

Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment.
od: Olof Elvstam, i wsp.
Wydane: (2017-01-01)

Virological Outcomes Among Pregnant Women Receiving Antiretroviral Treatment in the Amhara Region, North West Ethiopia
od: Endalamaw Alamneh D, i wsp.
Wydane: (2023-05-01)

Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda
od: Adah Tumwegamire, i wsp.
Wydane: (2024-01-01)

Interferon-γ-Inducible Protein 10 (IP-10) Kinetics after Antiretroviral Treatment Initiation in Ethiopian Adults with HIV
od: Johannes Thorman, i wsp.
Wydane: (2021-12-01)

Growth pattern in Ethiopian infants – the impact of exposure to maternal HIV infection in relation to socio-economic factors
od: John König Walles, i wsp.
Wydane: (2017-01-01)

How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy
od: Anthony Jaworowski, i wsp.
Wydane: (2019-06-01)

Determinants of Virologic Failure among Adult HIV Patients on First-Line Antiretroviral Therapy at Waghimra Zone, Northern Ethiopia: A Case-Control Study
od: Abrham Emagnu, i wsp.
Wydane: (2020-01-01)

Factors Affecting Virological Failure in Children Receiving First-Line Antiretroviral Therapy in Ethiopian Healthcare Facilities: A Retrospective Analysis
od: Desalegn M, i wsp.
Wydane: (2024-05-01)

HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study
od: Abraham Aregay Desta, i wsp.
Wydane: (2020-01-01)

Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
od: Prendergast, A, i wsp.
Wydane: (2008)

Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of “test and treat”
od: Joseph Fokam, i wsp.
Wydane: (2019-11-01)

Predictors of Virological Failure in HIV Patients Receiving First Line Antiretroviral Therapy with Good Adherence
od: Farid Kurniawan, i wsp.
Wydane: (2017-03-01)

Virological suppression in children and adolescents is not influenced by genotyping, but depends on optimal adherence to antiretroviral therapy
od: Juliana Costa de Abreu, i wsp.
Wydane: (2017-05-01)

Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana.
od: Katherine T Steele, i wsp.
Wydane: (2011-01-01)

Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
od: Marta Iglis Oliveira, i wsp.
Wydane: (2018-10-01)

HIV-genetic diversity and drug resistance transmission clusters in Gondar, Northern Ethiopia, 2003-2013.
od: Dawit Assefa Arimide, i wsp.
Wydane: (2018-01-01)

Long-Term Immunological and Virological Outcomes in Children Receiving Highly Active Antiretroviral Therapy at Hawassa University College of Medicine and Health Sciences, Southern Ethiopia
od: Demissie Assegu Fenta, i wsp.
Wydane: (2021-01-01)

“Virological Outcomes Among Pregnant Women Receiving Antiretroviral Treatment in the Amhara Region, North West Ethiopia” by Alamneh et al [Letter]
od: Wake AD
Wydane: (2023-05-01)

Factors associated with virological non-suppression among HIV-positive children receiving antiretroviral therapy at the Joint Clinical Research Centre in Lubowa, Kampala Uganda.
od: Sarah Nabukeera, i wsp.
Wydane: (2021-01-01)

Virological Non-Suppression among Newly Diagnosed HIV-Positive Individuals on Dolutegravir-Based Antiretroviral Treatment in Eastern Ethiopia: Follow-Up Study
od: Abdella Gemechu, i wsp.
Wydane: (2023-07-01)

Virological failure among people living with HIV receiving second-line antiretroviral therapy in Pune, India
od: Sonali Salvi, i wsp.
Wydane: (2022-12-01)

Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy
od: Zied Gaifer MBBS, MD, i wsp.
Wydane: (2020-12-01)

Combination anti‐HIV antibodies to achieve antiretroviral therapy‐free virological suppression in infected individuals
od: M. Ali Rai, i wsp.
Wydane: (2022-09-01)

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
od: Mulugeta Melku, i wsp.
Wydane: (2020-08-01)

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.
od: Nicola Gianotti, i wsp.
Wydane: (2017-01-01)

How does HIV testing modality impact the cascade of care among persons diagnosed with HIV in Ethiopia?
od: Malin Johansson, i wsp.
Wydane: (2021-01-01)

Tuberculosis infection and stillbirth in Ethiopia—A prospective cohort study
od: John Walles, i wsp.
Wydane: (2022-01-01)

Tuberculosis infection and stillbirth in Ethiopia-A prospective cohort study.
od: John Walles, i wsp.
Wydane: (2022-01-01)

Socioeconomic position and ten-year survival and virologic outcomes in a Ugandan HIV cohort receiving antiretroviral therapy.
od: Andrew G Flynn, i wsp.
Wydane: (2017-01-01)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial
od: Szubert, A, i wsp.
Wydane: (2017)

Factors associated with oxidative stress in virologically suppressed people living with HIV on long-term antiretroviral therapy
od: Francesca Lombardi, i wsp.
Wydane: (2024-12-01)

The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.
od: Michael Rosenblum, i wsp.
Wydane: (2009-09-01)

Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in Rakai, Uganda.
od: Alexander Billioux, i wsp.
Wydane: (2015-01-01)

Lived experiences of students with virological failure on antiretrovirals at a university in Limpopo
od: Mahlodi P. Maphakela, i wsp.
Wydane: (2023-10-01)

Virological and bacteriological quality of drinking water in Ethiopia
od: Tesfaye Legesse Bedada, i wsp.
Wydane: (2018-04-01)

Pregnancy and virologic response to antiretroviral therapy in South Africa.
od: Daniel Westreich, i wsp.
Wydane: (2011-01-01)

Viral Suppression and HIV Drug Resistance Among Patients on Second-Line Antiretroviral Therapy in Selected Health Facility in Ethiopia
od: Kidist Zealiyas, i wsp.
Wydane: (2025-01-01)